Table 2 |
|||||
|
Describe numbers of recovery according to treatment groups for each included study |
|||||
|
Author |
Treatment groups |
Recovery at 3 months |
Total N |
Recovery after 3 months |
Total N |
|
|
|||||
|
Adour et al. [8] |
Acy+Pred |
34 |
38 |
49 |
53 |
|
Pred |
20 |
29 |
35 |
46 |
|
|
De Diego[25] |
Acy |
42 |
54 |
- |
- |
|
Pred |
44 |
47 |
- |
- |
|
|
Engstorm et al. [9] |
Val+Pred |
134 |
206 |
149 |
206 |
|
Val |
113 |
207 |
120 |
207 |
|
|
Pred |
137 |
210 |
150 |
210 |
|
|
Plac |
111 |
206 |
127 |
206 |
|
|
Hato et al. [10] |
Val+Pred |
94 |
114 |
110 |
114 |
|
Pred |
80 |
107 |
96 |
107 |
|
|
Sullivan et al. [12] |
Acy+Pred |
99 |
124 |
115 |
124 |
|
Acy |
76 |
123 |
96 |
123 |
|
|
Pred |
109 |
127 |
122 |
127 |
|
|
Plac |
79 |
122 |
104 |
122 |
|
|
Yeo et al. [13] |
Acy + Pred |
36 |
44 |
41 |
44 |
|
Pred |
35 |
47 |
40 |
47 |
|
|
|
|||||
|
Numthavaj et al. BMC Neurology 2011 11:1 doi:10.1186/1471-2377-11-1 |
|||||
